Welcome To The Sinovac Biotech Ltd HUB China Securities
Sinovac is the only company in the world granted permission to begin clinical trials for a vaccine to prevent SARS
ChinaSecurities News Flash

HOT OFF THE CHINA SECURITIES BLOG ....

1. Canadian Solar (NASDAQ:CSIQ) - 4Q09 net revenues of $287.0 million 

Read More.



2. Gulf Resources (NASDAQ:GFRE) - Net income was $30.6 million, or $1.00 per basic and diluted share, a year-over-year increase of 36.6% from $22.4 million 

Read More.

 

 

3. DEER Consumer Products (NASDAQ:DEER) - Record Revenue of $81.3 million, an increase of 86% from $43.8 million in 2008 

Read More.

Sinovac Biotech Ltd Photo Gallery
3
Anflu
2
Bilive
1
Healive
Xin_4021202220830671134783
China starts human trials of bird flu vaccine
Yin-windows(large)_tcm18-113050
Yin Weidong, general manager of Sinovac Biotech
Executive Address
Sva - small
Sinovac Biotech Ltd
Welcome to Chinasecurities
May 24, 2009
Stock Quote
Hub Leaders